Related Experiment Video

Updated: Oct 21, 2025

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
10:58

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

7.7K

Spherical Nucleic Acid Vaccine Structure Markedly Influences Adaptive Immune Responses of Clinically Utilized

Michelle H Teplensky1, Jasper W Dittmar2, Lei Qin3

  • 1Department of Chemistry and the International Institute for Nanotechnology, Northwestern University, Evanston, IL, 60208, USA.

Advanced Healthcare Materials
|September 8, 2021
PubMed

Insights

This study shows that spherical nucleic acid (SNA) vaccines, precisely structured with prostate-specific membrane antigen (PSMA) or TARP peptides, significantly enhance immune responses against prostate cancer. These SNA vaccines activate potent T-cell activity and improve outcomes compared to traditional peptide vaccines.

Area of Science:

  • Immunology
  • Oncology
  • Biotechnology

Background:

  • Prostate cancer vaccines targeting specific proteins have shown limited success in clinical trials.
  • Existing peptide-based vaccines often fail to elicit a robust immune response.

Purpose of the Study:

  • To investigate the potential of spherical nucleic acid (SNA) technology to optimize vaccine architecture for improved prostate cancer immunotherapy.
  • To compare the efficacy of SNA-based vaccines with traditional peptide formulations.

Main Methods:

  • Engineered SNA vaccines incorporating peptides for prostate-specific membrane antigen (PSMA) and T-cell receptor gamma alternate reading frame protein (TARP).
  • Evaluated immune activation, cytokine production, T-cell responses, and cytolytic activity in humanized mice and human peripheral blood mononuclear cells (hPBMCs).

Main Results:

  • SNA vaccines demonstrated significantly higher immune activation and cytolytic ability compared to conventional formulations.
  • Treated mice and hPBMCs showed elevated cytokine production, increased polyfunctional cytotoxic T cells, and enhanced effector memory T cells.
  • T cells from immunized mice effectively killed PSMA-expressing cancer cells.

Conclusions:

  • Vaccine architecture is crucial for eliciting a potent antigen-specific immune response.
  • SNA technology offers a promising platform for reformulating existing peptide targets to improve prostate cancer vaccine efficacy.
  • This approach encourages re-evaluation of previously ineffective peptide targets for enhanced clinical outcomes.
Keywords:
humanized mice modelsnanotechnologyprostate cancerspherical nucleic acids (SNAs)vaccine immunotherapy

More Related Videos

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain08:07

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

2.8K
Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo07:33

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo

Published on: September 28, 2022

1.9K

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
569
Viral Structure00:56

Viral Structure

Viruses are extraordinarily diverse in shape and size, but they all have several structural features in common. All viruses have a core that contains a DNA- or RNA-based genome. The core is surrounded by a protective coat of proteins called the capsid. The capsid is composed of subunits called capsomeres. The capsid and genome-containing core are together known as the nucleocapsid.
67.4K
Conjugated Proteins02:50

Conjugated Proteins

Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
21.3K
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
797